In simple terms, a company can report profits but still run out of cash -- and when that happens, even the most successful ...

Perrigo Company plc (NYSE: PRGO) ("Perrigo" or "the Company"), a leading provider of consumer health products, today ...

Perrigo ( PRGO) on Wednesday said that it is initiating a strategic review of its infant formula business, which will assess ...

We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Perrigo Company plc (NYSE:PRGO) is one of the ...

Perrigo said on Wednesday it has initiated a strategic review of its infant formula business as the consumer health company ...

The current quarter introduced a downward revision to net sales and EPS guidance, with the new EPS range of $2.70 to $2.80 replacing the previous $2.90 to $3.10 target. Management now projects organic ...

Moody's Ratings revised the outlook on the Chicago Board of Education to stable from positive on Monday. Your complimentary ...

Perrigo is initiating a review of its infant formula business, citing an external environment that has made the segment's fit with the company's over-the-counter businesses less strategic, the company ...

Declares Dividend of $0.15 per share for Q3 2025 Represents Genco’s 25 th Consecutive Quarterly Dividend NEW YORK, Nov. 05, 2025 (GLOBE ...

Take-or-Pay Contract: Agreement obligating the purchaser to pay for a set volume of product whether or not it is physically delivered, stabilizing cash flows for the producer. Planned Turnaround: ...

Revenue of $274.1 million in Q2, ahead of outlookDiluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS ...

Perrigo (PRGO) announced that it is initiating a strategic review of its infant formula business. The review will assess a full range of ...